CXCR1 Expression in MDA-PCa-2b Cell Upregulates ITM2A to Inhibit Tumor Growth

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Chemokines and their receptors are crucial in cancer progression.
• Interleukin-8 (IL-8/CXCL8) promotes prostate cancer (PCa) angiogenesis, proliferation, and metastasis via CXCR1 and CXCR2.
• The specific role of CXCR1 in PCa progression was previously unclear.

Purpose of the Study:

• To investigate the functional role of CXCR1 in prostate cancer development.
• To compare the effects of CXCR1 and CXCR2 in an androgen-dependent PCa cell line.

Main Methods:

• Stable expression of CXCR1 and CXCR2 in the MDA-PCa-2b PCa cell line.
• Evaluation of tumor development, cell migration, proliferation, and protein expression in vitro and in vivo.
• RNA-sequencing and Western blot analysis to identify molecular changes.

Main Results:

• CXCR1 expression in MDA-PCa-2b cells reduced cell migration, AKT activation, PSA expression, proliferation, and tumor growth compared to controls and CXCR2-expressing cells.
• CXCR1 expression induced a mesenchymal-to-epithelial transition, indicated by altered E-cadherin, N-cadherin, and vimentin levels.
• CXCR1 expression significantly upregulated integral membrane protein 2A (ITM2A), a tumor suppressor, which was downregulated in prostate adenocarcinoma tissues.

Conclusions:

• CXCR1 expression in PCa cells may inhibit tumor development.
• Upregulation of ITM2A by CXCR1 appears to be a key mechanism in suppressing tumor growth.
• CXCR1 represents a potential therapeutic target for prostate cancer.